AlphaYouMS
Insider selling
Mark Schoenberg sold $300K of UroGen Pharma Ltd. (URGN) stock
Mark Schoenberg, Chief Medical Officer of UroGen Pharma Ltd. (URGN), sold 10,000 shares of URGN stock worth $300K, per an SEC Form 4 filed May 11, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 8, 2026, 3 days before it was made public.
URGN has moved +46.9% since the trade date, from $29.40 to $43.20 (Sep 21, 2026 close).
- Traded
- May 8, 2026
- Disclosed
- May 11, 2026
- Filing delay
- 3 days
- Price since
- +46.9%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More URGN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.